Staging and reporting of urothelial carcinoma of the urinary bladder

Liu, Cheng; Montironi, Rodolfo; Davidson, Darrell D.; López-Beltrán, Antonio

doi:10.1038/modpathol.2009.1

Cited by 172 publications

(141 citation statements)

References 137 publications

(173 reference statements)

Supporting

Mentioning

124

Contrasting

Unclassified

Order By: Relevance

“…Tumor size ranged 0.3-6 cm (mean= 2.3 cm) in largest diameter. In 124 (78%) cases, tumor size was less than 3cm (cut off= 3 cm) in the largest diameter and 35 (22%) tumors were more than 3cm (Cheng et al, 2009). Of this series of patients, in 41(26%) of cases the lamina propria were involved and 13 (8%) tumors showed muscular invasion.…”

Section: Study Population and Demographic Features Of Patientmentioning

confidence: 83%

See 1 more Smart Citation

ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder

Keymoosi¹,

Gheytanchi²,

Asgari³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Section: Study Population and Demographic Features Of Patientmentioning

confidence: 83%

“…The staging of UC was assessed according to AJCC (American joint committee on cancer) (Cheng et al, 2009). Patients' data were fully anonymous.…”

Section: Patients and Specimensmentioning

confidence: 99%

ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder

Keymoosi¹,

Gheytanchi²,

Asgari³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

“…A total of 14, 42 and 59 specimens were classified as papillary urothelial neoplasm of low malignant potential, low-grade urothelial carcinoma and high-grade urothelial carcinoma, respectively. Tumor staging was reviewed based on the 2009 Union for International Cancer Control-tumor node metastasis staging system (11). Accordingly, 7, 26, 58 and 24 tumors were staged T1, T2, T3 and T4, respectively.…”

Section: Methodsmentioning

confidence: 99%

CCR7 as a predictive biomarker associated with computed tomography for the diagnosis of lymph node metastasis in bladder carcinoma

Chen

Liu

et al. 2015

Oncology Letters

View full text Add to dashboard Cite

Abstract. The aim of the present study was to investigate whether the expression levels of CC-chemokine receptor 7 (CCR7) combined with computed tomography (CT) was associated with lymph node metastasis in bladder transitional cell carcinoma (BTCC). For this purpose, 115 cases of BTCC were analyzed at the Department of Urology of Xiangya Hospital, Central South University (Changsha, China). Preoperative CT scans of abdomen and pelvis, immunohistochemistry of CCR7 expression in the tumor specimens and pathological findings for lymph node metastasis were assessed. In addition, the sensitivity, specificity and accuracy of CCR7 and CT for the diagnosis of lymph node metastasis in BTCC were evaluated separately and jointly. The expression levels of CCR7 were observed to be significantly higher in BTCC than in normal controls (P<0.01). Multivariate analysis indicated that the overexpression of CCR7 was an independent predictor for lymph node metastasis in BTCC (P<0.05). The sensitivity, specificity and accuracy of CCR7 combined with CT scan for the diagnosis of lymph node metastasis in BTCC were 92.3, 83.6 and 70.0%, respectively. By contrast, the sensitivity, specificity and accuracy of CCR7 alone were 88.1, 69.9 and 76.5%, respectively, while the sensitivity, specificity and accuracy of CT alone were 52.4, 79.5 and 69.6%, respectively. The results of the present study indicated that CCR7 is an independent predictor of lymph node metastasis in BTCC. Therefore, the use of CCR7 combined with CT may improve the accuracy of the diagnosis of lymph node metastasis in BTCC.

show abstract

“…All patients did previous TUR and their biopsies referred to the Department of Pathology, Assuit University Hospital and diagnosed by histopathology as non-muscle invasive urothelial carcinoma of the bladder (All biopsies contain parts of muscle layer for correct assessment of tumor stage. Tumor staging and grading were done according to the AJCC/UICC TNM staging 2009 [8] and to the 2004 WHO classification criteria for malignant tumors of the urinary tract [9].…”

Section: Methodsmentioning

confidence: 99%

The Role of Cytologic Analysis in Follow-Up of Non-Muscle Invaisve Urothelial Cell Carcinoma in Relation to Cystoscopic Biopsy

Badary¹,

Reda²

2017

J Mol Biomark Diagn

View full text Add to dashboard Cite

Background: Bladder urothelial carcinoma has high recurrence rate so patients with bladder urothelial carcinoma have to be monitored thoroughly for disease recurrence, this makes bladder cancer one of the most expensive cancer types for the health care system. Voided urine cytology is the most commonly used noninvasive follow-up diagnostic tool. The purpose of this study was to assess the role of voided urine cytology for the follow-up of patients with non-muscle invasive urothelial carcinoma (NMIUC).

show abstract

Staging and reporting of urothelial carcinoma of the urinary bladder

Cited by 172 publications

References 137 publications

ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder

ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder

CCR7 as a predictive biomarker associated with computed tomography for the diagnosis of lymph node metastasis in bladder carcinoma

The Role of Cytologic Analysis in Follow-Up of Non-Muscle Invaisve Urothelial Cell Carcinoma in Relation to Cystoscopic Biopsy

Contact Info

Product

Resources

About